Date updated:05-29-2008
The biotech sector is anticipating a big weekend for cancer drugs in the ASCO conference. What is the trade?

-
IMCL
Imcl - $0.00
- N/A
- $N/A
We’re talking about lung cancer, explains CNBC Pharmaceuticals Reporter Mike Huckman. Look for headline-grabbing test results out of ImClone (IMCL).

-
DNA
Genentech Inc - $84.53
- +0.63%
- $83.52
Also keep an eye on Genetech (DNA), he says for two reasons 1) because the lung cancer data could have an impact on one of their drugs and Genentech should also deliver news on a breast cancer treatment.

-
LLY
Lilly Eli Co - $38.62
- -2.40%
- $39.06
As well as more details from Eli Lilly (LLY) on Alimta, its drug for lung cancer.

-
CELG
Celgene Corporati - $51.50
- +2.04%
- $50.05
In addition, Celgene (CELG) is another name to watch but keep in mind shares rallied when most of its study results were released two weeks ago.

-
BIIB
Biogen Idec Inc - $46.81
- +0.73%
- $46.13
As well as Biogen (BIIB) and Elan (ELN).

-
ELN
Elan Cp Plc Adr - $7.59
- -0.91%
- $7.85
As well as Biogen (BIIB) and Elan (ELN).
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Fidelity Select Consum...
- 5. Templeton World A (TEMWX)
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Stocks were mixed yesterday after retailers reported their numbers for the Christmas season. Wal-Mart (WMT), the nation's largest retailer, said December sales at stores...
Activist investing is never an easy task, but by following the latest activist filings, you can piggyback off of some of the smartest money managers and hedge funds ever. ...
Jim Cramer is optimistic on the stock market for 2009. According to his analysis, the Dow Jones Industrial Average could produce a gain of 13.1% this year based on his pred...
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
A. Better prospects out there right
now....could see some serious pain. I
think you could see a rally, but I can
think of many more compelling trades.
A. small trading before thrusday
This list consists of stocks that are down 10% or more in the last year but may be poised to surprise us on the upside going forward. The basis for the list is as follows: ... more
These are the stocks from Jim Cramer's latest Lightning Round. We list the stocks on which he is BULLISH and BEARISH. more
Here are the latest Activist or "13D" situations from the StreetInsider.com 13D Tracker page found at: http://www.13dtracker.blogspot.com/.... more






Comments not available